Impact of <i>CYP2D6*10</i> on recurrence‐free survival in breast cancer patients receiving adjuvant tamoxifen therapy
Kazuma Kiyotani(National Institute of Biomedical Innovation, Health and Nutrition), Hitoshi Zembutsu, Mitsunori Sasa(Tokushima Breast Care Clinic), Naoya Hosono, Ikuko Sumitomo(Tokushima Breast Care Clinic), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Taisei Mushiroda(RIKEN Center for Integrative Medical Sciences), Yusuke Nakamura(Rissho University), Yoshiyuki Bando(Tokushima University)
Cited by 181
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k